Performance of SARS-CoV-2 Antigens in a Multiplex Bead Assay for Integrated Serological Surveillance of Neglected Tropical and Other Diseases
Authors:
- Sarah GwynSGSarah Gwyn
- Ado AbubakarAAAdo Abubakar
- Eric BergeronEBEric Bergeron
- Ugboaja Nkechi BlessingUBUgboaja Nkechi Blessing
- Jasmine ChaitramJCJasmine Chaitram
- Melissa M. CoughlinMCMelissa M. Coughlin
- Ayuba B. DawurungADAyuba B. Dawurung
- Felicia Nwatu DicksonFDFelicia Nwatu Dickson
- Mudiaga EsiekpeMEMudiaga Esiekpe
- Erasogie EvbuomwanEEErasogie Evbuomwan
- Stacie M. GrebySGStacie M. Greby
Open Access
- 27 June 2022
- journal article
- research article
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 107 (2) , 260-267
Abstract
: Serosurveillance can provide estimates of population-level exposure to infectious pathogens and has been used extensively during the COVID-19 pandemic. Simultaneous, serological testing for multiple pathogens can be done using bead-based immunoassays to add value to disease-specific serosurveys. We conducted a validation of four SARS-CoV-2 antigens—full-length spike protein, two receptor binding domain proteins, and the nucleocapsid protein—on our existing multiplex bead assay (MBA) for enteric diseases, malaria, and vaccine preventable diseases. After determining the optimal conditions for coupling the antigens to microsphere beads, the sensitivity and specificity of the assay were determined on two instruments (Luminex-200 and MAGPIX) when testing singly (monoplex) versus combined (multiplex). Sensitivity was assessed using plasma from 87 real-time reverse transcription polymerase chain reaction (rRT-PCR) positive persons collected in March–May of 2020 and ranged from 94.3% to 96.6% for the different testing conditions. Specificity was assessed using 98 plasma specimens collected prior to December 2019 and plasma from 19 rRT-PCR negative persons and ranged from 97.4% to 100%. The positive percent agreement was 93.8% to 97.9% using 48 specimens collected > 21 days post-symptom onset, while the negative percent agreement was ≥ 99% for all antigens. Test performance was similar using monoplex or multiplex testing. Integrating SARS-CoV-2 serology with other diseases of public health interest could add significant value to public health programs that have suffered severe programmatic setbacks during the COVID-19 pandemic.Keywords
This publication has 39 references indexed in Scilit:
- Measuring Cryptosporidium Serologic Responses by Multiplex Bead Assay2019
- Integrated Serologic Surveillance of Population Immunity and Disease TransmissionEmerging Infectious Diseases, 2018
- Tetanus Immunity Gaps in Children 5–14 Years and Men ≥ 15 Years of Age Revealed by Integrated Disease Serosurveillance in Kenya, Tanzania, and MozambiqueThe American Journal of Tropical Medicine and Hygiene, 2017
- Lateral flow-based antibody testing for Chlamydia trachomatisJournal of Immunological Methods, 2016
- Integration of Multiplex Bead Assays for Parasitic Diseases into a National, Population-Based Serosurvey of Women 15-39 Years of Age in CambodiaPLOS Neglected Tropical Diseases, 2016
- Seroepidemiology ofToxoplasmain a coastal region of Haiti: multiplex bead assay detection of immunoglobulin G antibodies that recognize the SAG2A antigenEpidemiology and Infection, 2014
- Longitudinal Evaluation of Enteric Protozoa in Haitian Children by Stool Exam and Multiplex Serologic AssayThe American Journal of Tropical Medicine and Hygiene, 2014
- Development of a new platform for neglected tropical disease surveillanceInternational Journal for Parasitology, 2012
- Serology: a robust indicator of malaria transmission intensity?Trends in Parasitology, 2007
- Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposureProceedings of the National Academy of Sciences, 2005